Significant Insider Buying Observed in Key ETF Holdings
A recent analysis of the AGF U.S. Market Neutral Anti-Beta Fund (BTAL) reveals that 24.5% of its weighted holdings have seen insider buying in the last six months. This suggests increased confidence among company insiders regarding their firms’ prospects.
Pfizer Inc (PFE) – A Closer Look
Pfizer Inc (Symbol: PFE), which constitutes 13.84% of the AGF U.S. Market Neutral Anti-Beta Fund (BTAL), has recently attracted attention following purchases from two directors and officers. According to the latest Form 4 filings, the ETF currently holds $50,802,787 worth of PFE stock, ranking it as the #116 largest holding. Below is a summary of the recent insider transactions for PFE:
PFE – Last Trade: $25.55 – Recent Insider Buys:
Purchased | Insider | Title | Shares | Price/Share | Value |
---|---|---|---|---|---|
10/30/2024 | Scott Gottlieb | Director | 1,000 | $28.24 | $28,240 |
02/13/2025 | Ronald E. Blaylock | Director | 19,457 | $25.65 | $499,072 |
Match Group Inc (MTCH) – Insights on Recent Activity
Another notable component of the AGF U.S. Market Neutral Anti-Beta Fund (BTAL) is Match Group Inc (Symbol: MTCH), which ranks as the #139 largest holding. The ETF has invested $49,966,744 in MTCH, accounting for about 13.61% of the fund’s total assets. Recent Form 4 filings show that two directors and officers have engaged in share purchases. Below are the details of recent insider buying at MTCH:
MTCH – Last Trade: $31.27 – Recent Insider Buys:
Purchased | Insider | Title | Shares | Price/Share | Value |
---|---|---|---|---|---|
02/06/2025 | Spencer M. Rascoff | Chief Executive Officer | 59,560 | $34.41 | $2,049,704 |
02/06/2025 | Glenn Schiffman | Director | 3,000 | $34.47 | $103,410 |
10 ETFs With Stocks That Insiders Are Buying »
Also See:
• CYN Stock Predictions
• MTZ Average Annual Return
• ILAG shares outstanding history
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.